The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetic Neurological Disorder Therapeutic Drug Market Research Report 2025
Synopsis
A drug used to treat mental illness caused by diabetes
The global Diabetic Neurological Disorder Therapeutic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diabetic Neurological Disorder Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Neurological Disorder Therapeutic Drug.
Report Scope
The Diabetic Neurological Disorder Therapeutic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Neurological Disorder Therapeutic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Neurological Disorder Therapeutic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Johnson & Johnson
Takeda
Mitsubishi Chemical
Avanir Pharmaceuticals
Dong-A Pharmaceutical Co., Ltd.
Immune Pharmaceuticals
MediciNova
Sangamo BioSciences
Segment by Type
Capsule
Pills
Other
Segment by Application
Symmetrical Neuropathy
Focal and Multifocal Neuropathy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Neurological Disorder Therapeutic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A drug used to treat mental illness caused by diabetes
The global Diabetic Neurological Disorder Therapeutic Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Diabetic Neurological Disorder Therapeutic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetic Neurological Disorder Therapeutic Drug.
Report Scope
The Diabetic Neurological Disorder Therapeutic Drug market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetic Neurological Disorder Therapeutic Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetic Neurological Disorder Therapeutic Drug companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AstraZeneca
Johnson & Johnson
Takeda
Mitsubishi Chemical
Avanir Pharmaceuticals
Dong-A Pharmaceutical Co., Ltd.
Immune Pharmaceuticals
MediciNova
Sangamo BioSciences
Segment by Type
Capsule
Pills
Other
Segment by Application
Symmetrical Neuropathy
Focal and Multifocal Neuropathy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetic Neurological Disorder Therapeutic Drug companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Capsule
1.2.3 Pills
1.2.4 Other
1.3 Market by Application
1.3.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Symmetrical Neuropathy
1.3.3 Focal and Multifocal Neuropathy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Perspective (2019-2030)
2.2 Diabetic Neurological Disorder Therapeutic Drug Growth Trends by Region
2.2.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Region (2019-2024)
2.2.3 Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2025-2030)
2.3 Diabetic Neurological Disorder Therapeutic Drug Market Dynamics
2.3.1 Diabetic Neurological Disorder Therapeutic Drug Industry Trends
2.3.2 Diabetic Neurological Disorder Therapeutic Drug Market Drivers
2.3.3 Diabetic Neurological Disorder Therapeutic Drug Market Challenges
2.3.4 Diabetic Neurological Disorder Therapeutic Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue
3.1.1 Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Revenue (2019-2024)
3.1.2 Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Players (2019-2024)
3.2 Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetic Neurological Disorder Therapeutic Drug Revenue
3.4 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio
3.4.1 Global Diabetic Neurological Disorder Therapeutic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2023
3.5 Diabetic Neurological Disorder Therapeutic Drug Key Players Head office and Area Served
3.6 Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
3.7 Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Type
4.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Type (2019-2024)
4.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2025-2030)
5 Diabetic Neurological Disorder Therapeutic Drug Breakdown Data by Application
5.1 Global Diabetic Neurological Disorder Therapeutic Drug Historic Market Size by Application (2019-2024)
5.2 Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)
6.2 North America Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)
6.4 North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)
7.2 Europe Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)
7.4 Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)
8.2 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)
9.2 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)
9.4 Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size (2019-2030)
10.2 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Detail
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Introduction
11.1.4 AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.1.5 AstraZeneca Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Detail
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Introduction
11.2.4 Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.2.5 Johnson & Johnson Recent Development
11.3 Takeda
11.3.1 Takeda Company Detail
11.3.2 Takeda Business Overview
11.3.3 Takeda Diabetic Neurological Disorder Therapeutic Drug Introduction
11.3.4 Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.3.5 Takeda Recent Development
11.4 Mitsubishi Chemical
11.4.1 Mitsubishi Chemical Company Detail
11.4.2 Mitsubishi Chemical Business Overview
11.4.3 Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Introduction
11.4.4 Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.4.5 Mitsubishi Chemical Recent Development
11.5 Avanir Pharmaceuticals
11.5.1 Avanir Pharmaceuticals Company Detail
11.5.2 Avanir Pharmaceuticals Business Overview
11.5.3 Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
11.5.4 Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.5.5 Avanir Pharmaceuticals Recent Development
11.6 Dong-A Pharmaceutical Co., Ltd.
11.6.1 Dong-A Pharmaceutical Co., Ltd. Company Detail
11.6.2 Dong-A Pharmaceutical Co., Ltd. Business Overview
11.6.3 Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Introduction
11.6.4 Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.6.5 Dong-A Pharmaceutical Co., Ltd. Recent Development
11.7 Immune Pharmaceuticals
11.7.1 Immune Pharmaceuticals Company Detail
11.7.2 Immune Pharmaceuticals Business Overview
11.7.3 Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Introduction
11.7.4 Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.7.5 Immune Pharmaceuticals Recent Development
11.8 MediciNova
11.8.1 MediciNova Company Detail
11.8.2 MediciNova Business Overview
11.8.3 MediciNova Diabetic Neurological Disorder Therapeutic Drug Introduction
11.8.4 MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.8.5 MediciNova Recent Development
11.9 Sangamo BioSciences
11.9.1 Sangamo BioSciences Company Detail
11.9.2 Sangamo BioSciences Business Overview
11.9.3 Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Introduction
11.9.4 Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
11.9.5 Sangamo BioSciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Capsule
Table 3. Key Players of Pills
Table 4. Key Players of Other
Table 5. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2019-2024)
Table 9. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2025-2030)
Table 11. Diabetic Neurological Disorder Therapeutic Drug Market Trends
Table 12. Diabetic Neurological Disorder Therapeutic Drug Market Drivers
Table 13. Diabetic Neurological Disorder Therapeutic Drug Market Challenges
Table 14. Diabetic Neurological Disorder Therapeutic Drug Market Restraints
Table 15. Global Diabetic Neurological Disorder Therapeutic Drug Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players (2019-2024)
Table 17. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2023)
Table 18. Ranking of Global Top Diabetic Neurological Disorder Therapeutic Drug Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetic Neurological Disorder Therapeutic Drug Product Solution and Service
Table 22. Date of Enter into Diabetic Neurological Disorder Therapeutic Drug Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2019-2024)
Table 26. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Type (2025-2030)
Table 28. Global Diabetic Neurological Disorder Therapeutic Drug Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Application (2019-2024)
Table 30. Global Diabetic Neurological Disorder Therapeutic Drug Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Diabetic Neurological Disorder Therapeutic Drug Revenue Market Share by Application (2025-2030)
Table 32. North America Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size by Country (2025-2030) & (US$ Million)
Table 47. AstraZeneca Company Detail
Table 48. AstraZeneca Business Overview
Table 49. AstraZeneca Diabetic Neurological Disorder Therapeutic Drug Product
Table 50. AstraZeneca Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 51. AstraZeneca Recent Development
Table 52. Johnson & Johnson Company Detail
Table 53. Johnson & Johnson Business Overview
Table 54. Johnson & Johnson Diabetic Neurological Disorder Therapeutic Drug Product
Table 55. Johnson & Johnson Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 56. Johnson & Johnson Recent Development
Table 57. Takeda Company Detail
Table 58. Takeda Business Overview
Table 59. Takeda Diabetic Neurological Disorder Therapeutic Drug Product
Table 60. Takeda Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 61. Takeda Recent Development
Table 62. Mitsubishi Chemical Company Detail
Table 63. Mitsubishi Chemical Business Overview
Table 64. Mitsubishi Chemical Diabetic Neurological Disorder Therapeutic Drug Product
Table 65. Mitsubishi Chemical Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 66. Mitsubishi Chemical Recent Development
Table 67. Avanir Pharmaceuticals Company Detail
Table 68. Avanir Pharmaceuticals Business Overview
Table 69. Avanir Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
Table 70. Avanir Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 71. Avanir Pharmaceuticals Recent Development
Table 72. Dong-A Pharmaceutical Co., Ltd. Company Detail
Table 73. Dong-A Pharmaceutical Co., Ltd. Business Overview
Table 74. Dong-A Pharmaceutical Co., Ltd. Diabetic Neurological Disorder Therapeutic Drug Product
Table 75. Dong-A Pharmaceutical Co., Ltd. Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 76. Dong-A Pharmaceutical Co., Ltd. Recent Development
Table 77. Immune Pharmaceuticals Company Detail
Table 78. Immune Pharmaceuticals Business Overview
Table 79. Immune Pharmaceuticals Diabetic Neurological Disorder Therapeutic Drug Product
Table 80. Immune Pharmaceuticals Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 81. Immune Pharmaceuticals Recent Development
Table 82. MediciNova Company Detail
Table 83. MediciNova Business Overview
Table 84. MediciNova Diabetic Neurological Disorder Therapeutic Drug Product
Table 85. MediciNova Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 86. MediciNova Recent Development
Table 87. Sangamo BioSciences Company Detail
Table 88. Sangamo BioSciences Business Overview
Table 89. Sangamo BioSciences Diabetic Neurological Disorder Therapeutic Drug Product
Table 90. Sangamo BioSciences Revenue in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024) & (US$ Million)
Table 91. Sangamo BioSciences Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Type: 2023 VS 2030
Figure 3. Capsule Features
Figure 4. Pills Features
Figure 5. Other Features
Figure 6. Global Diabetic Neurological Disorder Therapeutic Drug Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Application: 2023 VS 2030
Figure 8. Symmetrical Neuropathy Case Studies
Figure 9. Focal and Multifocal Neuropathy Case Studies
Figure 10. Diabetic Neurological Disorder Therapeutic Drug Report Years Considered
Figure 11. Global Diabetic Neurological Disorder Therapeutic Drug Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Diabetic Neurological Disorder Therapeutic Drug Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Region: 2023 VS 2030
Figure 14. Global Diabetic Neurological Disorder Therapeutic Drug Market Share by Players in 2023
Figure 15. Global Top Diabetic Neurological Disorder Therapeutic Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetic Neurological Disorder Therapeutic Drug as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Diabetic Neurological Disorder Therapeutic Drug Revenue in 2023
Figure 17. North America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)
Figure 19. United States Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)
Figure 23. Germany Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Diabetic Neurological Disorder Therapeutic Drug Market Share by Region (2019-2030)
Figure 31. China Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)
Figure 39. Mexico Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Diabetic Neurological Disorder Therapeutic Drug Market Share by Country (2019-2030)
Figure 43. Turkey Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Diabetic Neurological Disorder Therapeutic Drug Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. AstraZeneca Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 46. Johnson & Johnson Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 47. Takeda Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 48. Mitsubishi Chemical Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 49. Avanir Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 50. Dong-A Pharmaceutical Co., Ltd. Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 51. Immune Pharmaceuticals Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 52. MediciNova Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 53. Sangamo BioSciences Revenue Growth Rate in Diabetic Neurological Disorder Therapeutic Drug Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
